FDA grants SeaStar Medical breakthrough device designation for its SCD therapy
ICU•The FDA granted SeaStar Medical’s SCD therapy breakthrough device designation for treating hyperinflammation in adults with sepsis or a septic condition.
1. FDA designation
The FDA granted SeaStar Medical’s SCD therapy breakthrough device designation for treating hyperinflammation in adult patients with sepsis or a septic condition.
